These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36069406)

  • 1. Inter- and Intraindividual Differences in the Capacity of the Human Intestinal Microbiome in Fecal Slurries to Metabolize Fructoselysine and Carboxymethyllysine.
    van Dongen KCW; Belzer C; Bakker W; Rietjens IMCM; Beekmann K
    J Agric Food Chem; 2022 Sep; 70(37):11759-11768. PubMed ID: 36069406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro model for microbial fructoselysine degradation shows substantial interindividual differences in metabolic capacities of human fecal slurries.
    van Dongen KCW; van der Zande M; Bruyneel B; Vervoort JJM; Rietjens IMCM; Belzer C; Beekmann K
    Toxicol In Vitro; 2021 Apr; 72():105078. PubMed ID: 33429044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaerobic Degradation of N-ε-Carboxymethyllysine, a Major Glycation End-Product, by Human Intestinal Bacteria.
    Bui TPN; Troise AD; Fogliano V; de Vos WM
    J Agric Food Chem; 2019 Jun; 67(23):6594-6602. PubMed ID: 31091091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in gut microbial fructoselysine degradation activity between breast-fed and formula-fed infants.
    van Dongen KCW; Ioannou A; Wesseling S; Beekmann K; Belzer C
    FEMS Microbiol Ecol; 2022 Dec; 99(1):. PubMed ID: 36442156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated Oral Exposure to N
    ALJahdali N; Gadonna-Widehem P; Delayre-Orthez C; Marier D; Garnier B; Carbonero F; Anton PM
    Dig Dis Sci; 2017 Dec; 62(12):3370-3384. PubMed ID: 28965192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study of the Effects of Dietary-Free and -Bound Nε-Carboxymethyllysine on Gut Microbiota and Intestinal Barrier.
    Yuan X; Liu J; Nie C; Ma Q; Wang C; Liu H; Chen Z; Zhang M; Li J
    J Agric Food Chem; 2024 Mar; 72(9):5014-5025. PubMed ID: 38388339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioremediation of a Common Product of Food Processing by a Human Gut Bacterium.
    Wolf AR; Wesener DA; Cheng J; Houston-Ludlam AN; Beller ZW; Hibberd MC; Giannone RJ; Peters SL; Hettich RL; Leyn SA; Rodionov DA; Osterman AL; Gordon JI
    Cell Host Microbe; 2019 Oct; 26(4):463-477.e8. PubMed ID: 31585844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome-Metabolomics Analysis of the Impacts of Long-Term Dietary Advanced-Glycation-End-Product Consumption on C57BL/6 Mouse Fecal Microbiota and Metabolites.
    Qu W; Nie C; Zhao J; Ou X; Zhang Y; Yang S; Bai X; Wang Y; Wang J; Li J
    J Agric Food Chem; 2018 Aug; 66(33):8864-8875. PubMed ID: 30037223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Lactobacillus fermentum ME-3 Treatment on Glycation and Diabetes Complications.
    Guilbaud A; Howsam M; Niquet-Léridon C; Delguste F; Fremont M; Lestavel S; Maboudou P; Garat A; Schraen S; Onraed B; Foligné B; Boulanger É; Tessier FJ
    Mol Nutr Food Res; 2020 Mar; 64(6):e1901018. PubMed ID: 31991062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic transit of dietary advanced glycation end-products - the case of N
    Tessier FJ; Boulanger E; Howsam M
    Glycoconj J; 2021 Jun; 38(3):311-317. PubMed ID: 32990827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Fecal Microbiota Composition in Older Adults With Frailty.
    Xu Y; Wang Y; Li H; Dai Y; Chen D; Wang M; Jiang X; Huang Z; Yu H; Huang J; Xiong Z
    Front Cell Infect Microbiol; 2021; 11():696186. PubMed ID: 34485176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of Individual Maillard Reaction Products in the Presence of the Human Colonic Microbiota.
    Hellwig M; Bunzel D; Huch M; Franz CM; Kulling SE; Henle T
    J Agric Food Chem; 2015 Aug; 63(30):6723-30. PubMed ID: 26186075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer.
    Wendel U; Persson N; Risinger C; Bengtsson E; Nodin B; Danielsson L; Welinder C; Nordin Fredrikson G; Jansson B; Blixt O
    PLoS One; 2018; 13(2):e0191872. PubMed ID: 29420566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro study to assess the impact of tetracycline on the human intestinal microbiome.
    Jung JY; Ahn Y; Khare S; Gokulan K; Piñeiro SA; Cerniglia CE
    Anaerobe; 2018 Feb; 49():85-94. PubMed ID: 29294359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial.
    Yacoub R; Nugent M; Cai W; Nadkarni GN; Chaves LD; Abyad S; Honan AM; Thomas SA; Zheng W; Valiyaparambil SA; Bryniarski MA; Sun Y; Buck M; Genco RJ; Quigg RJ; He JC; Uribarri J
    PLoS One; 2017; 12(9):e0184789. PubMed ID: 28931089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Exogenous Dietary Advanced Glycation End Products on the Cross-Talk Mechanisms Linking Microbiota to Metabolic Inflammation.
    Mastrocola R; Collotta D; Gaudioso G; Le Berre M; Cento AS; Ferreira Alves G; Chiazza F; Verta R; Bertocchi I; Manig F; Hellwig M; Fava F; Cifani C; Aragno M; Henle T; Joshi L; Tuohy K; Collino M
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32824970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the N
    Graf von Armansperg B; Koller F; Gericke N; Hellwig M; Jagtap PKA; Heermann R; Hennig J; Henle T; Lassak J
    Mol Microbiol; 2021 Feb; 115(2):175-190. PubMed ID: 32979851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure of
    Dubois C; Litke R; Rianha S; Paul-Constant C; Lo Guidice JM; Taront S; Tessier FJ; Boulanger E; Fradin C
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolization of the Advanced Glycation End Product N-ε-Carboxymethyllysine (CML) by Different Probiotic E. coli Strains.
    Hellwig M; Auerbach C; Müller N; Samuel P; Kammann S; Beer F; Gunzer F; Henle T
    J Agric Food Chem; 2019 Feb; 67(7):1963-1972. PubMed ID: 30701968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.